Pancreatic Cancer Research

ResearcherLoma Linda UniversityNo recent work listed

Gary Yang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103748016. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer. Last author DOI 10.21037/jgo-22-327↗
  2. Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848. Last author DOI 10.3978/j.issn.2078-6891.2014.094↗
  3. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. Co-author DOI 10.3978/j.issn.2078-6891.2013.045↗
  4. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. Last author DOI 10.3978/j.issn.2078-6891.2012.029↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samrat M. Sanghvi · 1 shared paper, 2022 · strength 0.15
  2. Alex Coffman · 1 shared paper, 2022 · strength 0.15
  3. Chung-Tsen Hsueh · 1 shared paper, 2022 · strength 0.15
  4. Kilian Salerno May · 2 shared papers, 2012–2013 · strength 0.06
  5. Nadia Karen Malik · 2 shared papers, 2012–2013 · strength 0.06
  6. Boris W. Kuvshinoff · 2 shared papers, 2012–2013 · strength 0.06
  7. Renuka V. Iyer · 2 shared papers, 2012–2013 · strength 0.06
  8. Ted Chen-Tai Ling · 1 shared paper, 2015 · strength 0.05
  9. Wen Wee Ma · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.